The Maintaining Innovation and Safe Technologies Act requires the U.S. Department of Health and Human Services to issue Medicare Part B payment guidance by January 1, 2027, for remote monitoring devices that use artificial intelligence. This guidance will clarify payment rules for devices like continuous glucose monitors, which must have an AI component (e.g., automatic adjustments) and transmit patient data to healthcare providers for treatment management. The bill directly affects Medicare coverage for these AI-enabled medical devices, used by patients managing chronic conditions such as diabetes. It does not change current reimbursement rates but mandates clear payment criteria through updated guidance by the specified deadline.
HR 584, the "No Medicaid for Illegal Immigrants Act of 2025," would amend the Social Security Act to prohibit states from providing Medicaid coverage to non-citizens who are not lawfully admitted for permanent residence or permanently residing in the U.S. under legal status. This bill directly affects undocumented immigrants who currently qualify for Medicaid in some states. The key provision inserts a new requirement that states cannot offer Medicaid benefits (except for specific emergency care) to these individuals under any state Medicaid plan or waiver. The change would prevent federal Medicaid funding from being used for this group, effectively eliminating their eligibility.
HR 44, the Rural 340B Access Act of 2025, would expand eligibility for the federal 340B drug discount program to include specific rural emergency hospitals. It directly affects rural emergency hospitals owned or operated by state/local governments, non-profits with governmental powers, or private non-profits with contracts to serve low-income patients. The bill amends the law to formally add these hospitals as "covered entities" under the 340B program, allowing them to purchase discounted drugs. This change would enable these facilities to access the same drug discounts previously available to other safety-net providers.
The Food Farmacy Act of 2025 authorizes $10 million annually (2026-2030) in federal grants to fund "healthy food pharmacies" that provide free nutritious food and nutrition guidance from qualified health professionals to low-income, rural, or food-insecure communities. These pharmacies must serve Medicaid/SNAP recipients at no cost and align with the Department of Health and Human Services' "Food is Medicine" initiative. Grants cover construction, equipment, staffing, and food acquisition, with recipients required to report annual data on patrons served, health outcomes, and program effectiveness. The bill directly supports communities facing food insecurity by integrating grocery access with healthcare services, targeting non-profits, local governments, and tribal organizations.
The Safeguarding Medicaid Act (S 1082) requires all Medicaid applicants and recipients in every state and territory to undergo an asset test, removing previous exemptions for people who are aged, blind, or disabled. It sets the resource limit for eligibility at the same level used for Supplemental Security Income (SSI) benefits, meaning individuals with assets above this threshold would be ineligible for Medicaid. The bill also mandates states to implement electronic asset verification systems within one year of enactment and report annually on the number of asset checks conducted during eligibility renewals and new applications. This affects all Medicaid applicants and recipients nationwide, with states required to track and report savings from these verification efforts to the federal government.
The Kidd's Stuttering Act requires Medicaid and CHIP to screen children aged 2-6 for stuttering and speech fluency during routine well-child visits starting January 1, 2027. It also mandates that Medicaid and CHIP cover specified speech therapy services for childhood stuttering (defined as "specified speech therapy services") with coverage rules no more restrictive than those for other speech disorders like language delays. The bill ensures these services include telehealth options and applies to all states administering Medicaid or CHIP. This directly affects children with stuttering who qualify for Medicaid or CHIP, aiming to improve early detection and access to treatment.
This bill requires Medicare to create separate billing codes for ultralightweight manual wheelchairs based on their frame material (e.g., titanium/carbon fiber vs. other materials) starting in 2026. It directly affects Medicare beneficiaries who use these wheelchairs, particularly those purchasing or renting models with titanium or carbon fiber frames. The bill mandates that Medicare pays suppliers the standard rate for such wheelchairs regardless of material, but allows suppliers to charge beneficiaries the difference between that payment and their actual cost. It also requires suppliers to provide clear financial notices to patients before sale or rental to inform them of potential additional costs.
This bill prohibits states from pursuing or collecting Medicaid recovery claims against individuals' estates for payments made during their lifetime. It requires states to withdraw all existing recovery liens within 90 days of enactment and notify affected individuals or their estates. The law specifically ends state efforts to reclaim Medicaid funds from beneficiaries' estates after death, applying to claims initiated before the law's effective date. It directly affects Medicaid beneficiaries and their estates who were subject to prior state recovery actions. The key mechanism is a mandatory 90-day withdrawal of all existing liens and a permanent ban on new recovery claims for correctly paid assistance.
Radiation Oncology Case Rate Value Based Program Act of 2025 or the ROCR Value Based Program Act This bill establishes a specialized payment program under Medicare for providers and suppliers of radiation oncology services. Specifically, the Centers for Medicare & Medicaid Services (CMS) must establish a program under which radiation therapy providers (i.e., hospital outpatient departments) and suppliers (i.e., physician group practices and freestanding radiation therapy centers) receive payments for each episode of care provided to individuals with specified types of cancer. An episode of care means the period beginning on the day radiation therapy planning is furnished to the individual and ending (1) for individuals with bone or brain metastases, 30 days later; and (2) for individuals with other cancer types, 90 days later. Participation in the program is mandatory for providers and suppliers that participate in Medicare, unless the provider or supplier is part of a state-based Center for Medicare & Medicaid Innovation model or qualifies for a significant hardship exemption. The CMS must set payment rates for the program based on national payment rates with specified adjustments (e.g., geographic adjustments). Providers and suppliers who provide certain transportation services for individuals under their care may receive an additional payment. Providers and suppliers must be accredited in accordance with certain standards, subject to payment reductions. The Government Accountability Office must report on (1) implementation of the program, and (2) underserved areas that are in need of more or newer radiation therapy resources.
The Patients Before Middlemen Act (S 882) improves pharmacy access for Medicare beneficiaries by requiring prescription drug plans to allow any pharmacy meeting standard contract terms to join their networks. It establishes "essential retail pharmacies" in medically underserved areas or regions with limited pharmacy access (such as rural areas with no other pharmacies within 10 miles), and creates standards for reasonable and relevant contract terms between drug plans and pharmacies. The bill also increases transparency requirements for pharmacy benefit managers, mandating detailed annual reports on drug costs, rebates, and pricing practices, with many provisions taking effect for plan years beginning January 1, 2028.
